Introduction
The discovery of the antifungal activity of azole compounds represented an important therapeutic advance [1] [2] [3] [4] [5] . Within them, Econazole, widely used as an antifungal drug [6] , is currently further investigated for additional therapeutic effects. In fact, both econazole and ketoconazole (1 nM -1 µM) decreased human breast cancer MCF-7 cell proliferation in a time and dose-dependent manner [7] . In addition, tumor growth was slightly delayed in liposomal econazole-treated mice [8] . Moreover, significant anti-tumorigenesis effect was demonstrated in vivo by treating nude mice bearing COLO 205 tumor xenograpfts with econazole 50 mg/kg intraperitoneally [9] and the same researchers also reported that lower doses of econazole (5 -20 µM) arrested human colon cancer cells at G0/G1 phase of the cell cycle. Different molecular mechanisms stay behind the clinical effects of drugs. It is well established that Ca 2+ is among the major intracellular factors involved in the signaling transduction pathways evoking cell growth and proliferation, and other key processes such as gene expression [10, 11] . When calcium signaling is stimulated in a cell, Ca 2+ enters the cytoplasm from one of two general sources: it is released from intracellular stores, or it enters the cell across the plasma membrane. Both processes often occur either simultaneously or sequentially [12] . Within Ca 2+ mechanisms contributing to the increases in intracellular Ca 2+ concentration ([Ca 2+ ] i ), particular attention has been paid to the role of Ca 2+ entry through store-operated channels (SOC) [13] . Thus, store-operated Ca 2+ entry (SOCE), a refilling process triggered by depletion of Ca 2+ stores, has been involved in cell signaling occurring in non-excitable cells to evoke different cell processes including gene regulation and cell growth [14] . Entry in cell cycle is preceded by SOC activation [15] and SOCE inhibition by different means abolishes tumor cell proliferation [16] [17] [18] [19] . In addition, alterations in intracellular Ca 2+ homeostasis are commonly observed during apoptosis [20, 21] and it has been demonstrated that the depletion of the endoplasmic reticulum Ca 2+ stores can directly induce apoptosis [22] . Although several reports have already suggested the antitumor effect of econazole, its molecular mechanism of action is still unclear. Being calcium signaling an essential tool for the development of different cellular responses as cell proliferation or apoptosis [23] [24] [25] [26] and being colorectal cancer one of the commonest tumors in the Westernized world [27] , the present study aims to investigate the role of econazole on Ca 2+ signaling in a human adenocarcinoma cell line. Previous reports showed the effect of econazole on Ca 2+ movements in different cell lines [28] [29] [30] , but our paper is the first to investigate the role of econazole on Ca 2+ signaling in HT29 cells.
Materials and Methods
HT29 cells were kindly donated by C. Villalobos (CSIC, Valladolid). Fura-2/AM was purchased from Fluka. Carbachol, econazole, PMA, propanolol, staurosporine and thapsigargin from Sigma. U73122 and nifedipine from Calbiochem. Reagents for cell culture were purchased from GIBCO. The human colorectal adenocarcinoma cell line HT29 was maintained in standard DMEM, (complemented with 10% fetal bovine serum (FBS), 1% peniciline/ streptomicine and 1% glutamine) and kept in an incubator (37ºC, 10% CO 2 humidified atmosphere). Cells were propagated in 75 cm 2 ] i was calculated using the method of Grynkiewicz et al. [31] . Increases in [Ca2+] i were expressed as nM (mean ± SD).
Mn

2+ measurements
Mn 2+ measurements were performed as previously described by our group in HT29 and other cell types [32, 33] . Briefly, Mn 2+ uptake was monitored as a rate of quenching of Fura-2 fluorescence measured at the Ca 2+ -insensitive wavelengths (excitation 360 nm and emission 510 nm). The rate of the fluorescence decrease provides a relative measure of the divalent cations permeability. Analysis of statistical significance was performed using Statgraphics Centurion XVI. The data are represented as mean ± SD for each group. One-way ANOVA was used to analyse the statistical significance between mean values followed by a least-significant difference (LSD) test. p < 0.05 was taken as the minimum level of significance.
Results
Econazole increased [Ca 2+ ] i in a concentration-dependent manner in the presence of extracellular Ca 2+ in HT29 cells. Fig. 1 ] i rise in HT29 cells. Statistical differences (p < 0.05) were found when comparing econazole response in control cells and Ni 2+ -treated cells (Fig. 3) .
In order to elucidate the origin of the calcium recruited by econazole, we used thapsigargin (Tg). Tg without acting on IP 3 receptors, increases cytosolic Ca 2+ by inhibiting the Ca 2+ -ATPase present on the endoplasmic reticulum [34] . Application of 400 nM Tg, in a Ca 2+ -free medium, caused an [Ca 2+ ] i increase that comprised an initial rise and a gradual decay towards baseline; after depleting the endoplasmic reticulum Ca 2+ store with Tg, addition of 10 µM econazole did not induce any Ca 2+ increase, thus suggesting that the internal Ca 2+ source for the econazole response is the Tg-sensitive endoplasmic reticulum store (Fig. 4) ] i via the production of inositol 1,4,5-triphosphate (IP 3 ). We used U73122, a PLC inhibitor, to block formation of IP 3 [35] [36] [37] . In cells treated with U73122 econazole-induced [Ca 2+ ] i was significantly curtailed (Fig. 5) . Econazole is generally recognized as an inhibitor of SOCE in a number of cells [38] [39] [40] , so we asked next whether it was able to inhibit SOCE in human colorectal adenocarcinoma cells. Carbachol (Cch) activates M 3 muscarinic receptors in HT29 cells provoking a biphasic [Ca 2+ ] i increase, a peak due to the transient release from intracellular stores followed by a plateau due to sustained Ca 2+ entry via store-operated channels (SOC) [41] . Thus, we were tempted to assess whether econazole inhibited SOCE induced by a physiological stimulation with Cch in HT29 cells. Econazole inhibited [Ca 2+ ] i increase induced by carbachol in a dose-dependent manner. The maximum effect was observed when 10 µM econazole was tested (Fig. 6 ). Both 0.1 and 1 µM of econazole failed to induce any inhibitory effect (data not shown). We developed experiments with Mn 2+ , used as a tracer for Ca 2+ entry [42] , in order to establish whether the econazole-induced decrease in [Ca 2+ ] i was actually due to an inhibition of Ca 2+ influx. We used Tg to induce SOCE. Fig. 7 shows how econazole inhibited Mn 2+ influx in cells treated with Tg.
Since it has been previously demonstrated the SOCEinhibitory properties of phorbol 12-myristate 13-acetate (PMA), in several cell types [43, 44] , we tested the effect of such a phorbol in HT29 cells. Fig. 8 , but it remains to be uncertain the type of channels implicated, as nifedipine, an L-type channels antagonist, failed to inhibit the entry, in clear connection with previous reports [28, 29] . Moreover, a phospholipase D (PLD) pathway did not seem to be implicated in econazole response, as cells treated with propanolol failed to abolish the econazole response. Concerning the stores implicated in the econazoleinduced Ca 2+ release, thapsigargin-sensitive stores proved to be econazole's target, as demonstrated for different cell lines [28, 29] . U73122, a pharmacological inhibitor of PLC, significantly abolished the econazoleinduced rise in [Ca 2+ ] i . Activation of PLC produces of Ca 2+ entry inhibition is, inhibition of SOCE has been shown to block cell proliferation in tumour cells [17, 18] . If SOC-E is essential for cell proliferation then it follows that drugs interfering with such a pathway may prevent cell proliferation via SOC-inactivation. Núñez et al. reported SOCE-inhibition as a novel mechanism that may contribute to explain the reported anti-proliferative and anti-tumoral actions of aspirin and dietary salicylates, which is also in agreement with several groups reporting that the inhibition of SOCE contributes to the anti-proliferative effect of drugs in human colon cancer cells [17] [18] [19] . In this sense, our results could be even connected with those previously stated demonstrating that low doses of econazole induce growth inhibition in colon cancer cells trough G0/G1 cell cycle arrest [9] . Econazole is widely used in different clinical preparations, but its effects on HT29 cells had not been previously examined. Our results show that econazole significantly alters Ca 2+ movements in these cells. Apart from its role as a SOCE blocker, it induces dose-dependent increases in [Ca 2+ ] i both by releasing Ca 2+ from the thapsigarginsentitive stores and by inducing extracellular calcium influx. As Ca 2+ entry into the cytoplasm influences the expression and activity of intracellular kinases and gene expression [23] [24] [25] [26] , we conclude that econazole may modify the physiology of human adenocarcinoma HT29 cells. IP 3 and diaylglycerol, which activates PKC. However, econazole-induced Ca 2+ increase was not inhibited by treating the cells with staurosporine, a PKC inhibitor, thus suggesting that the [Ca 2+ ] i rise observed after treating the cells with econazole was apparently not dependent on PKC activation. Because Ca 2+ overloading is known to initiate processes leading to cell death [46] , our results may suggest a molecular mechanism of action for the reported apoptotic properties of econazole [9] . Econazole has been shown to inhibit store-operated Ca 2+ entry in several cell types, so we explored the effect of econazole in HT29 cells. In fact, our results showed that econazole greatly inhibited SOCE induced by physiological stimulation with carbachol. In agreement with previous studies for several cell lines [47, 48] , we have demonstrated that activation of PKC, using phorbol esters, produces inhibition of agonist-induced [Ca 2+ ] i rise in HT29 cells. However, such a pathway was not involved in the inhibitor effect induced by econazole, as cells treated with staurosporine, failed to prevent such an inhibition. The lack of further evidence let us support those studies suggesting a link between a wide range of cytochrome P450 inhibitors and their role as blockers of SOCE [49, 50] . However, other studies disagree on this hypothesis [38, 40, 51] reporting that other imidazole compounds failed to have such an effect. Moreover, previous reports [52] showed that adding BSA removed the inhibitory effect of econazole in Ehrlich ascites tumour cells. In this context, it has been also demostrated that econazole did not inhibit I CRAC (Ca 2+ release-activated Ca 2+ channels) when injected intracellularly but did so when presented externally by patch clamp pipette [53] . But whatever the mechanism 
